ATE317016T1 - Herstellung rekombinanter künstlicher hefe- chromosome, welche das genom des humanen cytomegalovirus enthalten - Google Patents
Herstellung rekombinanter künstlicher hefe- chromosome, welche das genom des humanen cytomegalovirus enthaltenInfo
- Publication number
- ATE317016T1 ATE317016T1 AT01994211T AT01994211T ATE317016T1 AT E317016 T1 ATE317016 T1 AT E317016T1 AT 01994211 T AT01994211 T AT 01994211T AT 01994211 T AT01994211 T AT 01994211T AT E317016 T1 ATE317016 T1 AT E317016T1
- Authority
- AT
- Austria
- Prior art keywords
- genome
- production
- human cytomegalovirus
- chromosomes containing
- yeast chromosomes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16741—Use of virus, viral particle or viral elements as a vector
- C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/20—Pseudochromosomes, minichrosomosomes
- C12N2800/206—Pseudochromosomes, minichrosomosomes of yeast origin, e.g. YAC, 2u
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/10—Vectors comprising a non-peptidic targeting moiety
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/705,400 US6692954B1 (en) | 2000-11-03 | 2000-11-03 | Generation of human cytomegalovirus yeast artificial chromosome recombinants |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE317016T1 true ATE317016T1 (de) | 2006-02-15 |
Family
ID=24833288
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01994211T ATE317016T1 (de) | 2000-11-03 | 2001-10-30 | Herstellung rekombinanter künstlicher hefe- chromosome, welche das genom des humanen cytomegalovirus enthalten |
Country Status (9)
Country | Link |
---|---|
US (1) | US6692954B1 (de) |
EP (1) | EP1356062B1 (de) |
AT (1) | ATE317016T1 (de) |
AU (1) | AU2002246634A1 (de) |
DE (1) | DE60117053T2 (de) |
DK (1) | DK1356062T3 (de) |
ES (1) | ES2255583T3 (de) |
HK (1) | HK1055762A1 (de) |
WO (1) | WO2002057437A2 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7217807B2 (en) * | 2002-11-26 | 2007-05-15 | Rosetta Genomics Ltd | Bioinformatically detectable group of novel HIV regulatory genes and uses thereof |
WO2005052159A1 (en) | 2003-11-28 | 2005-06-09 | The University Of Sydney | Latent phase viral interleukin-10-(vii-10) and uses thereof |
US8088902B2 (en) | 2004-04-05 | 2012-01-03 | The Rockefeller University | DNA virus microRNA and methods for inhibiting same |
KR20070072608A (ko) | 2004-10-22 | 2007-07-04 | 레비비코르 인코포레이션 | 유전자 변형된 면역계를 가지는 유제류 |
US9267132B2 (en) | 2007-10-08 | 2016-02-23 | Synthetic Genomics, Inc. | Methods for cloning and manipulating genomes |
EP2348827B1 (de) | 2008-10-27 | 2015-07-01 | Revivicor, Inc. | Immunsupprimierte huftiere |
DK2403944T3 (da) | 2009-03-06 | 2019-05-27 | Synthetic Genomics Inc | Methods for cloning and manipulating genomes |
EP2542676A1 (de) | 2010-03-05 | 2013-01-09 | Synthetic Genomics, Inc. | Verfahren zum klonen und manipulieren von genomen |
US9206435B2 (en) | 2012-08-31 | 2015-12-08 | Synthetic Genomics, Inc. | Crowding agent-induced nucleic acid transfer into a recipient host cell |
WO2014089158A1 (en) * | 2012-12-04 | 2014-06-12 | Merck Sharp & Dohme Corp. | Conditional replicating viral vectors |
WO2015047901A1 (en) * | 2013-09-24 | 2015-04-02 | Duke University | Compositions, methods and kits for eliciting an immune response |
WO2016168741A2 (en) * | 2015-04-16 | 2016-10-20 | Spencer Juliet V | Detection of human cytomegalovirus |
CN110291402B (zh) | 2016-06-27 | 2023-09-01 | 朱诺治疗学股份有限公司 | 鉴定肽表位的方法、结合此类表位的分子和相关用途 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3959466A (en) | 1974-04-15 | 1976-05-25 | The Wistar Institute | Highly attenuated cytomegalovirus vaccine and production thereof |
US5591439A (en) | 1989-03-24 | 1997-01-07 | The Wistar Institute Of Anatomy And Biology | Recombinant cytomegalovirus vaccine |
US5552143A (en) | 1989-03-24 | 1996-09-03 | The Wistar Institute Of Anatomy & Biology | Recombinant cytomegalovirus vaccine |
WO1995003400A1 (en) | 1993-07-23 | 1995-02-02 | Johns Hopkins University School Of Medicine | Recombinationally targeted cloning in yeast artificial chromosomes |
US5721354A (en) | 1995-03-31 | 1998-02-24 | Aviron | Human cytomegalovirus DNA sequences |
DE19733364A1 (de) | 1997-08-01 | 1999-02-04 | Koszinowski Ulrich H Prof | Verfahren zur Klonierung eines großen Virusgenoms |
US6277621B1 (en) | 1998-02-26 | 2001-08-21 | Medigene, Inc. | Artificial chromosome constructs containing foreign nucleic acid sequences |
-
2000
- 2000-11-03 US US09/705,400 patent/US6692954B1/en not_active Expired - Fee Related
-
2001
- 2001-10-30 EP EP01994211A patent/EP1356062B1/de not_active Expired - Lifetime
- 2001-10-30 DE DE60117053T patent/DE60117053T2/de not_active Expired - Fee Related
- 2001-10-30 WO PCT/US2001/047943 patent/WO2002057437A2/en active IP Right Grant
- 2001-10-30 AT AT01994211T patent/ATE317016T1/de not_active IP Right Cessation
- 2001-10-30 DK DK01994211T patent/DK1356062T3/da active
- 2001-10-30 AU AU2002246634A patent/AU2002246634A1/en not_active Abandoned
- 2001-10-30 ES ES01994211T patent/ES2255583T3/es not_active Expired - Lifetime
-
2003
- 2003-11-04 HK HK03107960A patent/HK1055762A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HK1055762A1 (en) | 2004-01-21 |
EP1356062A2 (de) | 2003-10-29 |
DE60117053D1 (de) | 2006-04-13 |
WO2002057437A2 (en) | 2002-07-25 |
EP1356062B1 (de) | 2006-02-01 |
AU2002246634A1 (en) | 2002-07-30 |
DK1356062T3 (da) | 2006-05-15 |
DE60117053T2 (de) | 2006-08-17 |
US6692954B1 (en) | 2004-02-17 |
WO2002057437A3 (en) | 2003-08-14 |
ES2255583T3 (es) | 2006-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE317016T1 (de) | Herstellung rekombinanter künstlicher hefe- chromosome, welche das genom des humanen cytomegalovirus enthalten | |
DE69737886D1 (de) | Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays | |
WO2000003030A3 (en) | Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species | |
EP2336370A3 (de) | Rekombinante Newcastle-Disease-Virus RNA Expressionssysteme und Impfstoffe | |
EA200401506A1 (ru) | Рекомбинантный поксвирус, экспрессирующий гомологичные гены, встроенные в поксвирусный геном | |
NO874750D0 (no) | Bestemte dna-sekvenser avledet fra en papillomavirusgenom, deres bruk i in vitro diagnostikk og produksjon av antigene preparater. | |
PT1212358E (pt) | Genes sinteticos de papilomavirus humano | |
MXPA02005525A (es) | Clones infecciosos. | |
ATE369428T1 (de) | Behandlung von gebärmutterhalskrebs | |
HK1076835A1 (en) | Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter | |
EA200500879A1 (ru) | Рекомбинантный поксвирус, содержащий по меньшей мере два промотора ati коровьей оспы | |
DE60238309D1 (de) | Tomegalovirus genom mit konserviertem wildtyp-charakteristika klinisher isolate enthält | |
UA84667C2 (ru) | Вакцина, направленная против инфекции, вызванной вирусом герпеса болезни марека | |
AU2003255315A1 (en) | Vaccinia virus host range genes to increase the titer of avipoxviruses | |
WO2004067032A3 (en) | Identification of gene sequences and proteins involved in vaccinia virus dominant t cell epitopes | |
EP2172214A3 (de) | Chlamydia-Antigene und entsprechende DNA-Fragmente sowie Verwendungen davon | |
WO1995005460A3 (en) | Feline immunodeficiency virus isolate ncsu 1 | |
HUP0200320A2 (hu) | Macskaeredetű CD28-at, CD80-at, CD86-ot vagy CTL4-A-t expresszáló rekombináns vírusok és alkalmazásuk | |
DE69925927D1 (de) | Mutmassliches 98 kd protein des aussenmembrans von chlamydia und dafür kodierende dns sowie deren verwendung | |
HUP0103871A2 (hu) | Rekombináns CELO-vírus és CELO vírus DNS | |
BR9801992A (pt) | Processos para a preparação de vìrus da doença de marek usando linhas celulares contìnuas de mamìfero. | |
SE0002498D0 (sv) | Papillomavirus vaccine | |
WO2002097081A3 (en) | Method to generate non virulent microorganisms from pathogenic ones trough permanent genetic modification of their biological membrane for vaccine production | |
ATE359811T1 (de) | Verwendung von trehalose produzierenden prokaryotischen zellen als impfstoffe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |